
A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer
Weickhardt, Andrew, Doebele, Robert, Oton, Ana, Lettieri, Janice, Maxson, DeLee, Reynolds, Michele, Brown, Amy, Jackson, Mary K., Dy, Grace, Adjei, Araba, Fetterly, Gerald, Lu, Xian, Franklin, Wilbur,Volume:
7
Langue:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e31823c5b11
Date:
February, 2012
Fichier:
PDF, 522 KB
english, 2012